Larson Financial Group »

Cartesian Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $30 3 10.33

More positions owned by Larson Financial Group

Spdr Series Trust Portfolio S&p500 (SPLG)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Capital Group Global Equity SHS (CGGE)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Broadcom (AVGO)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)

View all positions for Larson Financial Group

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Siren
Vanguard Group
MPM Oncology Impact Management
Erste Asset Management GmbH
Geode Capital Management
683 Capital Management
State Street Corporation
Susquehanna International
Northern Trust
Citadel Advisors
GSA Capital Partners
Marshall Wace
Royal Bank of Canada

View all funds holding Cartesian Therapeutics